Epiberberine is an isomer of berlambine; it exhibits anti-adipogenesis effects by modulating the Akt and ERK pathways, anti-dyslipidemia effects by inhibition on cholesterol synthesis, anti-cancer effects by impacting the p53/Bax apoptosis pathway, and antibacterial activities (29). The gene discussed is MAPK1; the disease is metabolic syndrome.